96 related articles for article (PubMed ID: 21039054)
21. Association of XRCC1 gene polymorphisms with chronic myeloid leukemia in the population of Andhra Pradesh, India.
Annamaneni S; Gorre M; Kagita S; Addepalli K; Digumarti RR; Satti V; Battini MR
Hematology; 2013 May; 18(3):163-8. PubMed ID: 23320983
[TBL] [Abstract][Full Text] [Related]
22. Q192R and L55M Polymorphisms of Paraoxonase 1 Gene in Chronic Myelogenous Leukemia and Chronic Lymphocytic Leukemia.
Tomatir AG; Pehlivan S; Sahin HH; Balci SO; Budeyri S; Pehlivan M
Anticancer Res; 2015 Sep; 35(9):4807-12. PubMed ID: 26254371
[TBL] [Abstract][Full Text] [Related]
23. [Relation between single Nucleotide Polymorphisms of CYP3A5 Gene and MDR1 Gene Loci and Risk of CML Cytogenetic Relapse].
Yang ZY; Zhang YS; Liang CX; Zhou ZJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Dec; 26(6):1644-1648. PubMed ID: 30501698
[TBL] [Abstract][Full Text] [Related]
24. [Expression of CYP3A5 mRNA in children with acute leukemia].
Huang Z; Chai YH; Cen JN; He HL; Li J
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jul; 11(7):549-54. PubMed ID: 19650988
[TBL] [Abstract][Full Text] [Related]
25. Increased frequencies of glutathione-S-transferase (GSTM1 and GSTT1) null genotypes in Indian patients with chronic myeloid leukemia.
Bajpai P; Tripathi AK; Agrawal D
Leuk Res; 2007 Oct; 31(10):1359-63. PubMed ID: 17420047
[TBL] [Abstract][Full Text] [Related]
26. MTHFR 677CC/1298CC genotypes are highly associated with chronic myelogenous leukemia: a case-control study in Korea.
Moon HW; Kim TY; Oh BR; Min HC; Cho HI; Bang SM; Lee JH; Yoon SS; Lee DS
Leuk Res; 2007 Sep; 31(9):1213-7. PubMed ID: 17156840
[TBL] [Abstract][Full Text] [Related]
27. The impact of CYP3A5*3 on risk and prognosis in childhood acute lymphoblastic leukemia.
Borst L; Wallerek S; Dalhoff K; Rasmussen KK; Wesenberg F; Wehner PS; Schmiegelow K
Eur J Haematol; 2011 Jun; 86(6):477-83. PubMed ID: 21418106
[TBL] [Abstract][Full Text] [Related]
28. Impact of cytochrome P450 3A5 polymorphism in graft livers on the frequency of acute cellular rejection in living-donor liver transplantation.
Uesugi M; Kikuchi M; Shinke H; Omura T; Yonezawa A; Matsubara K; Fujimoto Y; Okamoto S; Kaido T; Uemoto S; Masuda S
Pharmacogenet Genomics; 2014 Jul; 24(7):356-66. PubMed ID: 24911663
[TBL] [Abstract][Full Text] [Related]
29. Study the polymorphism of CYP3A5 and CYP3A4 loci in Iranian population with laryngeal squamous cell carcinoma.
Azarpira N; Ashraf MJ; Khademi B; Darai M; Hakimzadeh A; Abedi E
Mol Biol Rep; 2011 Nov; 38(8):5443-8. PubMed ID: 21380731
[TBL] [Abstract][Full Text] [Related]
30. Genetic polymorphisms of the CYP3A4, CYP3A5, CYP3A7 and CYP1A2 among the Jordanian population.
Salameh G; Al Hadidi K; El Khateeb M
Environ Toxicol Pharmacol; 2012 Jul; 34(1):23-33. PubMed ID: 22426036
[TBL] [Abstract][Full Text] [Related]
31. Allele and genotype frequencies of CYP2B6 and CYP3A5 in the Japanese population.
Hiratsuka M; Takekuma Y; Endo N; Narahara K; Hamdy SI; Kishikawa Y; Matsuura M; Agatsuma Y; Inoue T; Mizugaki M
Eur J Clin Pharmacol; 2002 Sep; 58(6):417-21. PubMed ID: 12242601
[TBL] [Abstract][Full Text] [Related]
32. Variations in glutathione-S-transferase genes influence risk of chronic myeloid leukemia.
Özten N; Sunguroğlu A; Bosland MC
Hematol Oncol; 2012 Sep; 30(3):150-5. PubMed ID: 21969307
[TBL] [Abstract][Full Text] [Related]
33. CYP3A5 genotype-phenotype analysis in the human kidney reveals a strong site-specific expression of CYP3A5 in the proximal tubule in carriers of the CYP3A5*1 allele.
Bolbrinker J; Seeberg S; Schostak M; Kempkensteffen C; Baelde H; de Heer E; Kreutz R
Drug Metab Dispos; 2012 Apr; 40(4):639-41. PubMed ID: 22214815
[TBL] [Abstract][Full Text] [Related]
34. CYP3A5*3 and MDR-1 C3435T single nucleotide polymorphisms in six Chinese ethnic groups.
Lai Y; Zhang J; Wang YX; Wang XD; Li JL; Wang YH; Zeng YJ; Huang M
Pharmazie; 2011 Feb; 66(2):136-40. PubMed ID: 21434577
[TBL] [Abstract][Full Text] [Related]
35. Impact of
Maddin N; Husin A; Gan SH; Aziz BA; Ankathil R
Oncol Ther; 2016; 4(2):303-314. PubMed ID: 28261657
[TBL] [Abstract][Full Text] [Related]
36. Effect of CYP3A5 polymorphism on the pharmacokinetics of tacrolimus and acute rejection in renal transplant recipients: experience at a single centre.
Cheng Y; Li H; Meng Y; Liu H; Yang L; Xu T; Yu J; Zhao N; Liu Y
Int J Clin Pract Suppl; 2015 May; (183):16-22. PubMed ID: 26177012
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of genetic polymorphism of CYP3A5 in normal healthy participants from western India - A cross-sectional study.
Maurya MR; Gautam S; Raj JP; Saha S; Ambre S; Thakurdesai A; Shah A; Thatte UM
Indian J Pharmacol; 2022; 54(2):97-101. PubMed ID: 35546460
[TBL] [Abstract][Full Text] [Related]
38. Influence of BCL2-938C>A and BAX-248G>A promoter polymorphisms in the development of AML: case-control study from South India.
Cingeetham A; Vuree S; Dunna NR; Gorre M; Nanchari SR; Edathara PM; Meka P; Annamaneni S; Digumarthi R; Sinha S; Satti V
Tumour Biol; 2015 Sep; 36(10):7967-76. PubMed ID: 25957891
[TBL] [Abstract][Full Text] [Related]
39. CYP3A5 and NAT2 gene polymorphisms: role in childhood acute lymphoblastic leukemia risk and treatment outcome.
Silveira VS; Canalle R; Scrideli CA; Queiroz RG; Lopes LF; Tone LG
Mol Cell Biochem; 2012 May; 364(1-2):217-23. PubMed ID: 22215203
[TBL] [Abstract][Full Text] [Related]
40. [CYP2D6, CYP3A5, and CYP3A4 gene polymorphism in Russian, Tatar, and Bashkir populations].
Mustafina OE; Tuktarova IA; Karimov DD; Somova Rs; Nasibullin TR
Genetika; 2015 Jan; 51(1):109-19. PubMed ID: 25857198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]